US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OPUS GENETICS INC

3.61

+0.22006.49%

Volume:694.24K

Turnover:2.48M

Market Cap:248.96M

PE:-1.94

High:3.70

Open:3.40

Low:3.37

Close:3.39

52wk High:3.70

52wk Low:0.6500

Shares:68.96M

Float Shares:63.12M

Volume Ratio:0.44

T/O Rate:1.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8600

EPS(LYR):-2.1535

ROE:-338.75%

ROA:-60.73%

PB:41.72

PE(LYR):-1.68

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Mohawk,

BUZZ-U.S. STOCKS ON THE MOVE-Opus Genetics, MetaVia, Enbridge

Opus Genetics Raises $25 Million in Private Placement of Preferred Stock

Opus Genetics Inc - to Use Net Proceeds to Advance Its Gene Therapy Clinical Programs

THOMSON REUTERS

Opus Genetics Inc: Financing Is Being Led by Adage Capital Management, With Participation by Trails Edge Capital Partners and Marshall Wace

THOMSON REUTERS

Opus Genetics Announces $25 Million Private Placement

THOMSON REUTERS

Opus Genetics Inc - Expects Its Year-End 2025 Pro Forma Cash Balance of $70 Mln Will Fund Operations Into First Half of 2028

THOMSON REUTERS

Analysts Are Bullish on These Healthcare Stocks: Adaptive Biotechnologies (ADPT), Opus Genetics (IRD)

Iron Road (ASX:IRD) Might Have The Makings Of A Multi-Bagger

Simply Wall St.

Opus Genetics to Present Preliminary Results of OPGx-BEST1 Gene Therapy at Macula Society Annual Meeting

Opus Genetics Price Target Maintained With a $7.00/Share by BTIG

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Opus Genetics (IRD) and Argenx Se (ARGX)

Opus Genetics launches gene therapy clinical trial for retinitis pigmentosa

Opus Genetics Inc - Trial Funded by Abu Dhabi's Healthcare Research Fund

THOMSON REUTERS

Opus Genetics Inc - Clinical Development to Start at Cleveland Clinic Abu Dhabi in 2026

THOMSON REUTERS

Opus Genetics Launches Gene Therapy Clinical Trial for Mertk-Related Retinitis Pigmentosa

THOMSON REUTERS

Opus Genetics Inc : Btig Initiates Coverage With Buy Rating; Target Price $7

THOMSON REUTERS

Opus Genetics initiated with a Buy at BTIG

Opus Genetics Initiated at Buy by BTIG

Opus Genetics Inc: Expects Its Existing Cash Resources Will Fund Operations Into Second Half of 2027

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IRD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":3.61,"timestamp":1771016174002,"preClose":3.39,"halted":0,"volume":694239,"delay":0,"changeRate":0.06489675516224182,"floatShares":63122173,"shares":68964208,"eps":-1.86,"marketStatus":"Trading","change":0.22,"latestTime":"02-13 15:56:23 EST","open":3.4,"high":3.7,"low":3.37,"amount":2475661.827912,"amplitude":0.097345,"askPrice":3.62,"askSize":1408,"bidPrice":3.61,"bidSize":2131,"shortable":3,"etf":0,"ttmEps":-1.86,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771016400000},"marketStatusCode":2,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":3.39,"preHourTrading":{"tag":"盘前","latestPrice":3.4,"preClose":3.39,"latestTime":"09:02 EST","volume":16638,"amount":57058.490304,"timestamp":1770991368495,"change":0.01,"changeRate":0.00295,"amplitude":0.071563},"postHourTrading":{"tag":"盘后","latestPrice":3.39,"preClose":3.39,"latestTime":"18:52 EST","volume":2899,"amount":9825.23,"timestamp":1770940368077,"change":0,"changeRate":0,"amplitude":0.011799},"volumeRatio":0.437894,"impliedVol":4.0103,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":63122173,"roa":"-60.73%","roe":"-338.75%","lyrEps":-2.153504,"volumeRatio":0.437894,"shares":68964208,"dividePrice":0,"high":3.7,"amplitude":0.097345,"preClose":3.39,"low":3.37,"week52Low":0.65,"pbRate":"41.72","psRate":"17.01","week52High":3.7,"institutionHeld":0,"latestPrice":3.61,"committee":0.204295,"eps":-1.86,"divideRate":0,"volume":694239,"delay":0,"ttmEps":-1.86,"open":3.4,"prevYearClose":2.01,"prevWeekClose":3.01,"prevMonthClose":2.31,"prevQuarterClose":2.01,"fiveDayClose":3.01,"twentyDayClose":2.08,"sixtyDayClose":1.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"IRD","fiscalQuarterEnding":"2025/09","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-08-13","symbol":"IRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"IRD","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-03-31","symbol":"IRD","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-1.27},{"market":"US","date":"2024-11-12","symbol":"IRD","fiscalQuarterEnding":"2024/09","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1818,"buy":0.8182,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8182,"analysts":11,"updateTime":1768971600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2026-02-12","current":-1.822581,"percent":0.006211,"low":-3.528952,"twenty":-2.132649,"median":-1.323479,"eighty":-1.028003,"high":-0.560128,"avg":-1.515903,"sd":0.604048,"marketCap":226892244},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-06","current":-1.017762,"twenty":-1.393136,"median":-1.225421,"eighty":-0.767335,"marketCap":59661197},{"date":"2025-06-13","current":-1.009213,"twenty":-1.381526,"median":-1.207384,"eighty":-0.771254,"marketCap":59160042},{"date":"2025-06-20","current":-0.947842,"twenty":-1.372239,"median":-1.207384,"eighty":-0.771564,"marketCap":55562472},{"date":"2025-06-27","current":-1.038117,"twenty":-1.360629,"median":-1.184165,"eighty":-0.771642,"marketCap":60854420},{"date":"2025-07-03","current":-1.017762,"twenty":-1.358307,"median":-1.160946,"eighty":-0.77653,"marketCap":59661197},{"date":"2025-07-11","current":-1.139893,"twenty":-1.351342,"median":-1.160017,"eighty":-0.782117,"marketCap":66820540},{"date":"2025-07-18","current":-1.185692,"twenty":-1.346698,"median":-1.152239,"eighty":-0.783669,"marketCap":69505294},{"date":"2025-07-25","current":-1.231492,"twenty":-1.339732,"median":-1.160017,"eighty":-0.783669,"marketCap":72190048},{"date":"2025-08-01","current":-1.129716,"twenty":-1.335088,"median":-1.160248,"eighty":-0.785825,"marketCap":66223928},{"date":"2025-08-08","current":-1.10936,"twenty":-1.335088,"median":-1.151155,"eighty":-0.789762,"marketCap":65030704},{"date":"2025-08-15","current":-1.213067,"twenty":-1.335088,"median":-1.150071,"eighty":-0.791428,"marketCap":70691504},{"date":"2025-08-22","current":-1.177087,"twenty":-1.335088,"median":-1.151155,"eighty":-0.791428,"marketCap":68594722},{"date":"2025-08-29","current":-1.287434,"twenty":-1.335088,"median":-1.160248,"eighty":-0.791428,"marketCap":75025207},{"date":"2025-09-05","current":-1.384803,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"marketCap":80699383},{"date":"2025-09-12","current":-1.525447,"twenty":-1.342054,"median":-1.174821,"eighty":-0.822134,"marketCap":88895414},{"date":"2025-09-19","current":-1.611997,"twenty":-1.365273,"median":-1.182227,"eighty":-0.876364,"marketCap":93939125},{"date":"2025-09-26","current":-1.860829,"twenty":-1.384803,"median":-1.184928,"eighty":-0.929339,"marketCap":108439795},{"date":"2025-10-03","current":-1.947379,"twenty":-1.400101,"median":-1.195775,"eighty":-0.939944,"marketCap":113483507},{"date":"2025-10-10","current":-2.152936,"twenty":-1.42988,"median":-1.207384,"eighty":-0.94314,"marketCap":125462322},{"date":"2025-10-17","current":-2.174573,"twenty":-1.477844,"median":-1.207384,"eighty":-0.951343,"marketCap":126723249},{"date":"2025-10-24","current":-2.163754,"twenty":-1.521119,"median":-1.217191,"eighty":-0.957164,"marketCap":126092786},{"date":"2025-10-31","current":-2.131298,"twenty":-1.627334,"median":-1.225421,"eighty":-0.958345,"marketCap":124201394},{"date":"2025-11-07","current":-2.196211,"twenty":-1.661499,"median":-1.23256,"eighty":-0.960734,"marketCap":127984177},{"date":"2025-11-14","current":-2.001473,"twenty":-1.74585,"median":-1.242213,"eighty":-0.964942,"marketCap":116635827},{"date":"2025-11-21","current":-1.951541,"twenty":-1.828372,"median":-1.253822,"eighty":-0.975077,"marketCap":133100921},{"date":"2025-11-28","current":-2.153773,"twenty":-1.878321,"median":-1.253822,"eighty":-0.98727,"marketCap":146893763},{"date":"2025-12-05","current":-2.254889,"twenty":-1.925381,"median":-1.265432,"eighty":-0.988735,"marketCap":153790183},{"date":"2025-12-12","current":-2.467233,"twenty":-1.950709,"median":-1.277041,"eighty":-0.996674,"marketCap":168272667},{"date":"2025-12-19","current":-2.002099,"twenty":-2.002099,"median":-1.288651,"eighty":-1.007767,"marketCap":136549131},{"date":"2025-12-26","current":-2.062768,"twenty":-2.022322,"median":-1.288651,"eighty":-1.0085,"marketCap":140686984},{"date":"2026-01-02","current":-2.032433,"twenty":-2.02248,"median":-1.288651,"eighty":-1.00907,"marketCap":138618058},{"date":"2026-01-09","current":-2.022322,"twenty":-2.035652,"median":-1.288651,"eighty":-1.009619,"marketCap":137928416},{"date":"2026-01-16","current":-2.103215,"twenty":-2.062768,"median":-1.30026,"eighty":-1.016154,"marketCap":143445552},{"date":"2026-01-23","current":-2.527902,"twenty":-2.079519,"median":-1.303662,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-01-30","current":-2.527902,"twenty":-2.105793,"median":-1.31187,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-02-06","current":-2.608795,"twenty":-2.126582,"median":-1.317674,"eighty":-1.019861,"marketCap":177927656},{"date":"2026-02-12","current":-3.326719,"twenty":-2.132649,"median":-1.323479,"eighty":-1.028003,"marketCap":226892244}],"updateTime":1770979994803},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611090162","title":"BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Mohawk,","url":"https://stock-news.laohu8.com/highlight/detail?id=2611090162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611090162?lang=en_us&edition=fundamental","pubTime":"2026-02-14 02:35","pubTimestamp":1771007702,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Mohawk,Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL6N3Z90O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251142724.SGD","NEM","HWM","HK0000914660.USD","STLD","WEN","IE00B19Z3581.USD","IR","MRNA","DKNG","PINS","BK4114","EXPE","BIO","AAP","GB00BDT5M118.USD","IRD","NUE","HTGC","FDX","RYAN","LU0130102774.USD","DLTR","BK4534","LU0498741890.SGD","TOST","BK4505","WYNN","LU0130103400.USD","CDE","CART","ABNB","LU2764262908.HKD","CLF","IMUX","LU0205193047.USD","AMKR","PSA","LU1223083913.SGD","MTVA","CHRS","DXCM","TPH","HL","ROKU","MHK","BK4210","WTS","H"],"gpt_icon":1},{"id":"2611716894","title":"BUZZ-U.S. STOCKS ON THE MOVE-Opus Genetics, MetaVia, Enbridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2611716894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611716894?lang=en_us&edition=fundamental","pubTime":"2026-02-13 22:11","pubTimestamp":1770991868,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Opus Genetics, MetaVia, EnbridgeEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL6N3Z90O5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4561","WEN","IE00BZ9MQY76.HKD","TPH","LU0061474960.USD","LU0251144936.SGD","LU1868836591.USD","EXPE","AU","TOST","LU0055631609.USD","LU2237443549.SGD","BIO","LU0154236417.USD","MTVA","IE00BGHQF524.EUR","BK4535","PRU.UK","LU0130102774.USD","DLTR","LU0096362180.USD","NEM","HWM","CHRS","WTS","CDE","LU0661504455.SGD","ENB","LU1201861165.SGD","ROKU","AMKR","LU0211331839.USD","AAP","DKNG","BK4508","FDX","IE00B19Z3581.USD","PINS","RYAN","IRD","LU2491050154.USD","RIVN","CART","LU0310800965.SGD","BK4142","HL","IMUX","ABNB","LU0266512127.USD","HK0000914686.HKD"],"gpt_icon":0},{"id":"2611154692","title":"Opus Genetics Raises $25 Million in Private Placement of Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2611154692","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611154692?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:30","pubTimestamp":1770985813,"startTime":"0","endTime":"0","summary":"Opus Genetics Inc., a clinical-stage biopharmaceutical company focused on gene therapies for inherited retinal diseases, has announced a $25 million private placement of 7,374,632 shares of Series B Non-Voting Convertible Preferred Stock at $3.39 per share. The financing round is led by Adage Capital Management, with participation from Trails Edge Capital Partners and Marshall Wace. The shares and underlying common stock have not been registered under the Securities Act of 1933 and are subject to restrictions on transfer. Opus Genetics plans to use the proceeds to advance its gene therapy clinical programs and for general corporate purposes. The company expects the offering to close on February 18, 2026, subject to customary conditions, and anticipates the funds will support operations into the first half of 2028.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL3NSkTw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BKPKM429.USD","LU2095319765.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","LU0314104364.USD","BK4139","BK4112","IRD","BK4007","NDAQ","SG9999014013.SGD"],"gpt_icon":0},{"id":"2611545581","title":"Opus Genetics Inc - to Use Net Proceeds to Advance Its Gene Therapy Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2611545581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611545581?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:30","pubTimestamp":1770985800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nTUA7D4ZSX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IRD","BK4007"],"gpt_icon":0},{"id":"2611215466","title":"Opus Genetics Inc: Financing Is Being Led by Adage Capital Management, With Participation by Trails Edge Capital Partners and Marshall Wace","url":"https://stock-news.laohu8.com/highlight/detail?id=2611215466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611215466?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:30","pubTimestamp":1770985800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nTUA7D4ZSX:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IRD","BK4007"],"gpt_icon":0},{"id":"2611154582","title":"Opus Genetics Announces $25 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2611154582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611154582?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:30","pubTimestamp":1770985800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nTUA7D4ZSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","IRD"],"gpt_icon":0},{"id":"2611115458","title":"Opus Genetics Inc - Expects Its Year-End 2025 Pro Forma Cash Balance of $70 Mln Will Fund Operations Into First Half of 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2611115458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611115458?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:30","pubTimestamp":1770985800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nTUA7D4ZSX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4007","BK4139"],"gpt_icon":0},{"id":"2609594463","title":"Analysts Are Bullish on These Healthcare Stocks: Adaptive Biotechnologies (ADPT), Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609594463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609594463?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:21","pubTimestamp":1770387677,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Adaptive Biotechnologies (ADPT – Research Report) an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-adaptive-biotechnologies-adpt-opus-genetics-ird-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-adaptive-biotechnologies-adpt-opus-genetics-ird-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","BK4585","BK4121","BK4588","XBI","BK4007","ADPT","LABU","LU0128526141.USD","BK4112","BK4137","BK4139","IRD"],"gpt_icon":0},{"id":"2608481198","title":"Iron Road (ASX:IRD) Might Have The Makings Of A Multi-Bagger","url":"https://stock-news.laohu8.com/highlight/detail?id=2608481198","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608481198?lang=en_us&edition=fundamental","pubTime":"2026-02-03 06:47","pubTimestamp":1770072425,"startTime":"0","endTime":"0","summary":"If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ird/iron-road-shares/news/iron-road-asxird-might-have-the-makings-of-a-multi-bagger","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ird/iron-road-shares/news/iron-road-asxird-might-have-the-makings-of-a-multi-bagger","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IRD","IRD.AU","BK4007","BK7129","BK4139","EBIT"],"gpt_icon":0},{"id":"2608861851","title":"Opus Genetics to Present Preliminary Results of OPGx-BEST1 Gene Therapy at Macula Society Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2608861851","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608861851?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:00","pubTimestamp":1770037215,"startTime":"0","endTime":"0","summary":"Opus Genetics Inc. will participate in several upcoming medical and industry conferences in February 2026. The company’s leadership will join discussions at the Collaborative Community on Ophthalmic Innovation  and the Asia-Pacific Academy of Ophthalmology Congress , both taking place in Hong Kong from February 3-8, 2026. Additionally, Opus Genetics’ Chief Technology Officer, Chris Ernst, will speak at the Advanced Therapies Week Conference in San Diego, CA, on February 11, 2026. The company will also present preliminary results from a clinical study at the Macula Society Annual Meeting in San Diego, CA, on February 27, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to genera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL2wVhzg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU0314104364.USD","IRD","BK4585","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","BK4139","BK4588","SG9999014013.SGD","BK4007","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014005.SGD","SG9999014021.USD","BK4112","LU2095319765.USD","NDAQ"],"gpt_icon":0},{"id":"2606792917","title":"Opus Genetics Price Target Maintained With a $7.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2606792917","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606792917?lang=en_us&edition=fundamental","pubTime":"2026-01-28 18:17","pubTimestamp":1769595420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 28, 2026 05:17 ET (10:17 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"gpt_icon":0},{"id":"2606733627","title":"Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Opus Genetics (IRD) and Argenx Se (ARGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606733627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606733627?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:00","pubTimestamp":1769526036,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Intellia Therapeutics (NTLA – Research Report), Opus Genetics (IR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-intellia-therapeutics-ntla-opus-genetics-ird-and-argenx-se-argx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-intellia-therapeutics-ntla-opus-genetics-ird-and-argenx-se-argx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","BK4505","LU0889565916.HKD","IE00BFTCPJ56.SGD","HCSG","LU2324357040.USD","BK4007","LU1861559042.SGD","XBI","XLV","IE0034235188.USD","BK4137","IE00B4R5TH58.HKD","LU0029874061.USD","NTLA","BK4581","LU0320765992.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","BK4588","BK4535","IE0009355771.USD","LU1861558580.USD","IE0002141913.USD","BK4139","LU1983260115.SGD","LABU","IE00B2B36J28.USD","BK4585","ARGX","IRD","LU0128526141.USD","BK4556"],"gpt_icon":0},{"id":"2606781856","title":"Opus Genetics launches gene therapy clinical trial for retinitis pigmentosa","url":"https://stock-news.laohu8.com/highlight/detail?id=2606781856","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606781856?lang=en_us&edition=fundamental","pubTime":"2026-01-27 20:16","pubTimestamp":1769516171,"startTime":"0","endTime":"0","summary":"Opus Genetics (IRD) announced the launch and funding of its clinical trial evaluating a gene therapy for MERTK-related retinitis pigmentosa. The st...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-launches-gene-therapy-clinical-trial-for-retinitis-pigmentosa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-launches-gene-therapy-clinical-trial-for-retinitis-pigmentosa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRD","BK4007","BK4139"],"gpt_icon":0},{"id":"2606789886","title":"Opus Genetics Inc - Trial Funded by Abu Dhabi's Healthcare Research Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2606789886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606789886?lang=en_us&edition=fundamental","pubTime":"2026-01-27 20:00","pubTimestamp":1769515201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nTUAL7JFC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","IRD"],"gpt_icon":0},{"id":"2606786002","title":"Opus Genetics Inc - Clinical Development to Start at Cleveland Clinic Abu Dhabi in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2606786002","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606786002?lang=en_us&edition=fundamental","pubTime":"2026-01-27 20:00","pubTimestamp":1769515201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nTUAL7JFC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4007","BK4139"],"gpt_icon":0},{"id":"2606700786","title":"Opus Genetics Launches Gene Therapy Clinical Trial for Mertk-Related Retinitis Pigmentosa","url":"https://stock-news.laohu8.com/highlight/detail?id=2606700786","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606700786?lang=en_us&edition=fundamental","pubTime":"2026-01-27 20:00","pubTimestamp":1769515201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nTUAL7JFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4007","BK4139"],"gpt_icon":0},{"id":"2604941401","title":"Opus Genetics Inc : Btig Initiates Coverage With Buy Rating; Target Price $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2604941401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604941401?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:00","pubTimestamp":1768906833,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL09S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IRD","BK4007"],"gpt_icon":0},{"id":"2604494194","title":"Opus Genetics initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2604494194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604494194?lang=en_us&edition=fundamental","pubTime":"2026-01-20 18:45","pubTimestamp":1768905908,"startTime":"0","endTime":"0","summary":"BTIG analyst Thomas Shrader initiated coverage of Opus Genetics (IRD) with a Buy rating and $7 price target Opus is a developmental stage biotechno...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-initiated-with-a-buy-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-initiated-with-a-buy-at-btig-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IRD","BK4007"],"gpt_icon":0},{"id":"2604191641","title":"Opus Genetics Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2604191641","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604191641?lang=en_us&edition=fundamental","pubTime":"2026-01-20 18:22","pubTimestamp":1768904520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 05:22 ET (10:22 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","IRD"],"gpt_icon":0},{"id":"2601036620","title":"Opus Genetics Inc: Expects Its Existing Cash Resources Will Fund Operations Into Second Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2601036620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601036620?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:04","pubTimestamp":1767873869,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y9106:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4007","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":75,"code":"91000000","status":"200"}]}}